---
document_datetime: 2025-09-02 09:14:18
document_pages: 11
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/simbrinza-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: simbrinza-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 28.0815546
conversion_datetime: 2025-12-20 14:06:11.870131
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## SIMBRINZA

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific informationafterauthorisation(archive).

| Applicationnumber   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued²/ amendedon   | Product Information affected3   | Summary   |
|---------------------|----------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Article 61(3) /     | Notification acc.Article61(3)-Accepted | 01/09/2025                          |                                          | PL                              |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions areissuedforallotherprocedures.

3SmPC(Summary ofProductCharacteristics),AnnexII,Labelling,PL(PackageLeaflet).

2 A Commission decision(CD) is issued for procedures that affect the terms of the marketing authorisation(e.g.summary of product characteristics, annexII, labelling,package leaflet).The CDisissuedwithintwomonths of the opinionforvariationsfallingunderthescope ofArticle23.1a(a)ofRegulation(EU)No.712/2012,orwithinoneyearforotherprocedures.

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                                       | Update of the package leaflet with revised contact details of local representatives.                                                                                                                                                                                                                                                                                                                                                                                                                 |            |     | EMA/N/0000294245   |
|---------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------------|
| Variation type IB / EMA/VR/0000266776 | This was an applicationfor avariation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.a.1 Change in the manufacturer of a starting material/reagent/intermediate used in themanufacturingprocessoftheactive substanceorchangeinthemanufacturer (including where relevant quality control testing sites)of the activesubstance,where noPh.Eur.Certificate ofSuitability ispart of the approved dossier-B.I.a.1.z Other variation - Accepted | 17/07/2025 | N/A |                    |
| Variation type IB / EMA/VR/0000258106 | This was an application for a group of variations. B.II.e.6 Change in any part of the (primary) packaging material not in contact with the finishedproductformulation(suchascolour of flip-off caps, colour code rings on ampoules, change of needle shield (different plastic used))-B.1I.e.6.z Other changes - Accepted B.II.e.1.b Change in type of container or                                                                                                                                  | 02/05/2025 | N/A |                    |

<div style=\"page-break-after: always\"></div>

| addition of a new container-B.Il.e.1.b.3 Deletion of an immediate packaging containerthatdoesnotlead tothecomplete deletion of a strength or pharmaceutical form - Accepted B.II.e.7 Change in supplier of packaging components or devices (when mentioned in the dossier)-B.II.e.7.a Deletion of a supplier - Accepted B.II.e.7 Change in supplier of packaging components or devices(when mentioned in the dossier)-B.1I.e.7.aDeletion ofa supplier - Accepted B.II.e.7 Change in supplier of packaging   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|                                       | B.II.e.2 Change in the specification parameters and/or limits of the immediate packaging of the finished product - B.II.e.2.z Other changes-Accepted B.II.FINISHEDPRODUCT-B.II.zOther variation -Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |            |     |
|---------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IB / EMA/VR/0000262152 | Thiswas an applicationfor agroupof variations. B.I.b.1Changeinthespecification parameters and/or limits of an active substance,startingmaterial/intermediate/ reagentusedinthemanufacturingprocess of the active substance-B.I.b.1.d Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter) - Accepted B.I.b.1 Change in the specification parameters and/or limits of an active substance，startingmaterial/intermediate/ reagent used in themanufacturingprocess of the active substance-B.1.b.1.d Deletion ofanon-significantspecificationparameter (e.g. deletion of an obsolete parameter) - Accepted B.I.b.1 Change in the specification | 30/04/2025 | N/A |

<div style=\"page-break-after: always\"></div>

substance,startingmaterial/intermediate/ reagent used in the manufacturing process of the active substance -B.I.b.1.b Tightening of specification limits-Accepted

B.I.a.1 Change in the manufacturer of a starting material/reagent/intermediate used in the manufacturing process of the active substance orchange in themanufacturer (including where relevant quality control testing sites)of the active substance,where noPh.Eur.Certificate of Suitability is part of the approved dossier - B.I.a.1.z Other variation - Accepted

A.ADMINISTRATIVECHANGES-A.7 Deletion ofmanufacturingsitesfor an active substance, intermediate or finished product, packaging site, manufacturer responsible for batchrelease,sitewherebatchcontroltakes place, or supplier of a starting material, reagent or excipient(when mentioned in the dossier)*- Accepted

A.ADMINISTRATIVE CHANGES -A.4 Change in thename and/or address of:a manufacturer(includingwhererelevant quality control testing sites); or an ASMF holder; or a supplier of the active substance, startingmaterial,reagentorintermediate usedinthemanufactureof the active substance (where specified in the technical

<div style=\"page-break-after: always\"></div>

| dossier) where no Ph. Eur. Certificate of Suitability is part of the approved dossier; or a manufacturer of a novel excipient (where specified in the technical dossier)-Accepted  A.ADMINISTRATIVE CHANGES -A.4 Change in thename and/or addressof:a manufacturer(includingwhererelevant quality control testing sites);or anASMF holder; or a supplier of the active substance, startingmaterial,reagentorintermediate used in the manufacture of the active substance(where specified in the technical dossier)where noPh.Eur.Certificate of Suitabilityispartof theapproveddossier;or amanufacturerofanovelexcipient(where specified in the technical dossier) - Accepted  A. ADMINISTRATIVE CHANGES - A.4 Change in thename and/oraddressof:a manufacturer(includingwhererelevant quality control testing sites); or an ASMF holder; or a supplier of the active substance, startingmaterial,reagentorintermediate usedinthemanufactureof the active substance(where specified in the technical dossier)wherenoPh.Eur.Certificateof Suitabilityispartoftheapproveddossier;or a manufacturerofanovelexcipient(where specified in the technical dossier) - Accepted  B.I.a.2Changes in the manufacturing   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| process of the active substance - B.I.a.2.a                                    |
|--------------------------------------------------------------------------------|
| Minor change in the manufacturing process                                      |
| of the active substance-Accepted                                               |
| B.I.a.2 Changes in the manufacturing                                           |
| process of the active substance - B.I.a.2.a                                    |
| Minor change in the manufacturing process                                      |
| of theactivesubstance-Accepted                                                 |
| B.I.a.2 Changes in the manufacturing                                           |
| process of the active substance - B.I.a.2.a                                    |
| Minor change in the manufacturing process                                      |
| oftheactivesubstance-Accepted                                                  |
| B.I.a.2 Changes in the manufacturing                                           |
| process of the active substance - B.I.a.2.a                                    |
| Minor change in the manufacturing process                                      |
| of the active substance-Accepted                                               |
| B.I.a.2 Changes in the manufacturing                                           |
| process of the active substance - B.I.a.2.a                                    |
| Minor change in the manufacturingprocess                                       |
| of the activesubstance-Accepted                                                |
| B.I.a.2 Changes in the manufacturing                                           |
| process of the active substance - B.I.a.2.a                                    |
| Minor changein themanufacturingprocess                                         |
| of the active substance-Accepted                                               |
| B.I.b.1 Change in the specification                                            |
| parameters and/or limits of an active substance,startingmaterial/intermediate/ |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| reagent used in the manufacturing process changes - Accepted B.IACTIVESUBSTANCE-B.I.zOther variation - Accepted B.1.b.2 Change in testprocedure for active substance or starting manufacturing process of the active substance-B.I.b.2.aMinor changes to an approved test procedure-Accepted B.1.b.2 Change intest procedurefor active substanceorstarting material/reagent/intermediateused in the manufacturingprocessofthe active substance-B.I.b.2.aMinor changestoan approved test procedure-Accepted B.1.b.2 Change in test procedure for active substance or starting manufacturingprocessoftheactive substance-B.I.b.2.aMinor changestoan B.1.b.2 Change in testprocedurefor active material/reagent/intermediateused inthe   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| of the active substance - B.I.b.1.z Other                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| material/reagent/intermediate used in the                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| material/reagent/intermediate used in the                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| approved test procedure-Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| substance or starting                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| manufacturingprocessoftheactive                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

|                                       | substance -B.I.b.2.a Minor changes to an approved test procedure -Accepted B.I.a.4 Change to in-process tests or limits applied during the manufacture of the active substance-B.I.a.4.z Other variation- Accepted B.I.a.4 Change to in-process tests orlimits applied during the manufacture of the active substance-B.I.a.4.z Other variation- Accepted B.I.a.4 Change toin-process tests orlimits applied during the manufacture of the active substance -B.I.a.4.b Addition of a new in- process test and limits - Accepted B.I.a.4 Change to in-process tests or limits applied during the manufacture of the active substance-B.I.a.4.cDeletion of a non- significant in-process test-Accepted B.I.a.4 Change to in-process tests or limits applied during the manufacture of the active substance -B.I.a.4.z Other variation - Accepted   |            |     |
|---------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IA / EMA/VR/0000266066 | A. ADMINISTRATIVE CHANGES -A.4 Change in thename and/or addressof:a manufacturer(includingwhererelevant                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 15/04/2025 | N/A |

<div style=\"page-break-after: always\"></div>

|                                       | quality control testing sites); or an ASMF holder; or a supplier of the active substance, startingmaterial,reagentorintermediate usedinthemanufactureof the active substance (where specified in the technical dossier) where no Ph. Eur. Certificate of Suitability is part of the approved dossier; or amanufacturer of anovelexcipient(where specified in the technical dossier) - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                             |            |     |
|---------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IB / EMA/VR/0000248411 | B.1.b.2 Change in test procedure for active substance or starting material/reagent/intermediateusedinthe manufacturingprocessofthe active substance-B.1.b.2.c Other changes to a test procedure(includingreplacement or addition) for a reagent, which does not have a significant effect on the overall quality of theactivesubstance-Accepted B.I.a.1 Change in the manufacturer of a startingmaterial/reagent/intermediateused inthemanufacturingprocessoftheactive substance orchange in themanufacturer (including where relevant quality control testingsites)of theactivesubstance,where noPh.Eur.Certificate ofSuitability ispart of the approved dossier - B.I.a.1.f Changes to quality control testing arrangements for the active substance-replacement or addition of a site where batch control/testing takes | 11/03/2025 | N/A |

<div style=\"page-break-after: always\"></div>